Tuo Liang
-
- Neuropeptides and Animal Physiology 3
-
- Hormonal and reproductive studies 4
- Urology top 5%
- Reproductive Medicine top 10%
-
- Sexual Differentiation and Disorders 3
- Receptor Mechanisms and Signaling 3
- Steroid Chemistry and Biochemistry 3
-
- Parkinson's Disease Mechanisms and Treatments 4
-
- Aldose Reductase and Taurine 3
-
- Blood Pressure and Hypertension Studies 3
- Co-authors
- Sih‐Han LiaoGary G. ChicchiGary H. RasmussonA H CheungG. F. REYNOLDSWing‐Ho YungYa KeJohn L Tymoczko
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Tuo Liang
29 papers receiving 934 citations
Peers
Comparison fields: 5 of 94
- Cellular and Molecular Neuroscience 283
- Endocrinology, Diabetes and Metabolism 256
- Urology 71
- Reproductive Medicine 82
- Molecular Biology 464
Countries citing papers authored by Tuo Liang
This map shows the geographic impact of Tuo Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuo Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuo Liang more than expected).
Fields of papers citing papers by Tuo Liang
This network shows the impact of papers produced by Tuo Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuo Liang. The network helps show where Tuo Liang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tuo Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 3 | |
| 4 | 2023 | 6 | |
| 5 | 2023 | 5 | |
| 6 | 2021 | 6 | |
| 7 | 2020 | 18 | |
| 8 | 2019 | 11 | |
| 9 | 2019 | 3 | |
| 10 | 2017 | 1 | |
| 11 | 2016 | 4 | |
| 12 | Cardio-protecteffect of qiliqiangxin capsule on left ventricular remodeling, dysfunction and apoptosis in heart failure rats after chronic myocardial infarction. | 2016 | 24 |
| 13 | 2014 | 19 | |
| 14 | 2014 | 1 | |
| 15 | 2014 | 79 | |
| 16 | 2013 | 11 | |
| 17 | 1992 | 141 | |
| 18 | 1986 | 35 | |
| 19 | 1976 | 48 | |
| 20 | 1975 | 38 |
About Tuo Liang
Tuo Liang is a scholar working on Applied Microbiology and Biotechnology, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine, having authored 31 papers that have together received 976 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (4 papers), Hormonal and reproductive studies (4 papers), Aldose Reductase and Taurine (3 papers), Blood Pressure and Hypertension Studies (3 papers), Neuropeptides and Animal Physiology (3 papers), Sexual Differentiation and Disorders (3 papers), Receptor Mechanisms and Signaling (3 papers) and Steroid Chemistry and Biochemistry (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (283 citations), Endocrinology, Diabetes and Metabolism (256 citations) and Urology (71 citations). Tuo Liang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Sih‐Han Liao, Gary G. Chicchi, Gary H. Rasmusson, A H Cheung, G. F. REYNOLDS, Wing‐Ho Yung, Ya Ke, John L Tymoczko, Zhong‐Ming Qian and Lina Lü.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.